103 related articles for article (PubMed ID: 6428200)
21. [A case of untreatable progressive bladder carcinoma effectively treated by single administration of tegafur and uracil].
Goto R; Yoshikawa H; Ota M; Ikeuchi T; Kai Y
Gan To Kagaku Ryoho; 1998 Dec; 25(14):2287-91. PubMed ID: 9881087
[TBL] [Abstract][Full Text] [Related]
22. Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trial.
Tsuburaya A; Yoshida K; Kobayashi M; Yoshino S; Takahashi M; Takiguchi N; Tanabe K; Takahashi N; Imamura H; Tatsumoto N; Hara A; Nishikawa K; Fukushima R; Nozaki I; Kojima H; Miyashita Y; Oba K; Buyse M; Morita S; Sakamoto J
Lancet Oncol; 2014 Jul; 15(8):886-93. PubMed ID: 24954805
[TBL] [Abstract][Full Text] [Related]
23. Endocrine plus uracil/tegafur therapy for prostate cancer.
Ono Y; Ohshima S; Takahashi Y; Kuriyama M; Kawada Y; Shimizu H
Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):120-4. PubMed ID: 10442379
[TBL] [Abstract][Full Text] [Related]
24. [Clinical results of UFT against ovarian carcinoma].
Tanaka K; Kodama S; Nakamura M; Takahashi T; Honma S; Maruhashi T; Tokunaga A; Takeuchi Y; Sudou N; Adachi S
Gan To Kagaku Ryoho; 1994 Jul; 21(8):1229-33. PubMed ID: 8031166
[TBL] [Abstract][Full Text] [Related]
25. [Phase II study of UFT for head and neck cancer].
Inuyama Y; Takeda C; Miyake H; Fujii M; Tanaka J; Hirokawa T; Ooyama W; Horiuchi M; Uchida M; Kaneko S
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):479-84. PubMed ID: 3923939
[TBL] [Abstract][Full Text] [Related]
26. Prophylactic oral UFT therapy for superficial bladder cancer.
Kubota Y; Hosaka M; Fukushima S; Kondo I
Cancer; 1993 Mar; 71(5):1842-5. PubMed ID: 8448746
[TBL] [Abstract][Full Text] [Related]
27. [Effect of etoposide for pulmonary metastases from urogenital tract cancer].
Fujita K; Murayama T; Sayama T
Gan To Kagaku Ryoho; 1984 Nov; 11(11):2438-41. PubMed ID: 6497402
[TBL] [Abstract][Full Text] [Related]
28. [Combination chemotherapy with 5-FU and low-dose CDDP for urogenital tumors].
Fujinami K; Kubota Y
Gan To Kagaku Ryoho; 1999 Oct; 26(11):1559-63. PubMed ID: 10553413
[TBL] [Abstract][Full Text] [Related]
29. Phase II trial of oral uracil/tegafur plus leucovorin in patients with hormone-refractory prostate carcinoma.
Bhandari MS; Pienta KJ; Fardig J; Olson K; Smith DC
Cancer; 2006 Apr; 106(8):1715-21. PubMed ID: 16534795
[TBL] [Abstract][Full Text] [Related]
30. Pilot trial of a combination comprising of consecutive oral administration of UFT, and two-divided administration of CDDP in non-small cell lung cancer.
Gemma A; Kudoh S; Yoshimura A; Ono Y; Takenaka K; Hayashihara K; Hino M; Shibuya M; Niitani H
Anticancer Res; 1995; 15(6B):2691-5. PubMed ID: 8669849
[TBL] [Abstract][Full Text] [Related]
31. Phase II trial of UFT activity in pretreated breast cancer patients.
Daniels M; Díaz-Rubio E; Guillem V; Montero JM; García-Conde J; Estapé J; Martín M; Herranz C; Ordoñez A; Galán A
Jpn J Clin Oncol; 1993 Dec; 23(6):363-5. PubMed ID: 8283790
[TBL] [Abstract][Full Text] [Related]
32. Uracil-tegafur/leucovorin and mitomycin C salvage therapy in patients with advanced colorectal cancer: a phase II study.
Francois E; Smith D; Dahan L; Michel C; Perrier H; Mari V; Seitz JF; Follana P; Evesque L; Chamorey E
J Chemother; 2012 Aug; 24(4):207-11. PubMed ID: 23040684
[TBL] [Abstract][Full Text] [Related]
33. [Intra-arterial infusion of antineoplastic agents in the treatment of urogenital cancer].
Uyam T; Moriwaki S
Gan To Kagaku Ryoho; 1982 Mar; 9(3):415-20. PubMed ID: 7184407
[TBL] [Abstract][Full Text] [Related]
34. A phase II trial. Oral UFT and leucovorin in patients with advanced gastric carcinoma.
Kim YH; Shin SW; Kim BS; Park YT; Kim JG; Kim JS
Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):119-23. PubMed ID: 9348583
[TBL] [Abstract][Full Text] [Related]
35. A phase II study of epirubicin, cisplatin and uracil-tegafur for advanced gastric carcinoma.
Woo IS; Moon DH; Shim BY; Lee MA; Byun JH; Kim KW; Kang JH; Choi MG; Chung IS; Hong YS; Park SY; Lee KS
Jpn J Clin Oncol; 2005 Jan; 35(1):13-7. PubMed ID: 15681598
[TBL] [Abstract][Full Text] [Related]
36. [Pulmonary and lymph node metastases of renal cell carcinoma which completely responded to oral administration of UFT--a case report].
Hoshi K; Kanbara T; Kawasaki Y; Ikeda Y; Namima T; Ohnuma T
Gan To Kagaku Ryoho; 2007 Aug; 34(8):1315-7. PubMed ID: 17687222
[TBL] [Abstract][Full Text] [Related]
37. [A comparative clinical trial of UFT treatment and intravesical adriamycin instillation to prevent recurrence of superficial bladder cancer].
Masuda F; Mori Y; Torii S; Kawashima Y; Kobari T; Hosobe T
Gan To Kagaku Ryoho; 1992 Apr; 19(4):505-8. PubMed ID: 1558400
[TBL] [Abstract][Full Text] [Related]
38. [Phase I study of orally administered UFT plus l-leucovorin].
Horikoshi N; Aiba K; Kanamaru R; Hasegawa K; Takeda S; Taguchi T; Niitani H; Furue H; Kurihara M; Ogawa M; Abe T
Gan To Kagaku Ryoho; 1998 Mar; 25(4):531-9. PubMed ID: 9530359
[TBL] [Abstract][Full Text] [Related]
39. [Clinical trial of UFT in malignancies--an analysis of 337 patients. Co-operative Group for Clinical Study of UFT].
Zhonghua Zhong Liu Za Zhi; 1986 Sep; 8(5):373-6. PubMed ID: 3105987
[TBL] [Abstract][Full Text] [Related]
40. [Clinical effect of UFT in advanced renal cell carcinoma].
Hoshino M; Inoue K; Higaki M; Imamura K
Hinyokika Kiyo; 1988 Mar; 34(3):538-40. PubMed ID: 3133935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
